Chemioterapia versus naprzemienna chemio-radioterapia u chorych z organiczona postacia drobnokomorkowego raka pluca

Translated title of the contribution: Chemotherapy vs chemoradiotherapy in LD SCLC patients

D. Byszewska, A. Broniek, B. Jereczek, P. Oblakowski, T. Starzynska, J. Zych, K. Roszkowski

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

62 patients with a limited small cell lung cancer were randomly qualified into two groups. 32 patients of the first group were treated only with the chemotherapy regimen, consisting of three drugs (Carboplatine, Etoposide and Vincristine administered in 6 courses, on a regular, 3-weekly basis). The second group of 30 patients had been treated with the identical chemotherapy schedule, but alternatively combined with a primary site irradiation in a total dose of 40 Gy, applied in parts after the chemotherapy courses 2, 3, and 4. The significantly higher proportion of a complete remission results was observed in the alternate-treatment group: 14/30 (46,7%), compared with the chemotherapy-only group: 10/32 (31%). Alternate chemoradiotherapy resulted both in the increased median remission duration time, and the increased median survival time. Only in the alternate chemotherapy group, in 14/30 patients (46,7%) the pneumotoxicity symptoms appeared, whilst no differences in other organ-specific treatment-induced toxic effects were noted.

Original languagePolish
Pages (from-to)318-325
Number of pages8
JournalPneumonologia i Alergologia Polska
Volume65
Issue number5-6
Publication statusPublished - 1997

Fingerprint

Chemoradiotherapy
Drug Therapy
Poisons
Small Cell Lung Carcinoma
Vincristine
Etoposide
Appointments and Schedules
Survival
Therapeutics
Pharmaceutical Preparations

Keywords

  • chemoradiotherapy
  • chemotherapy
  • LD SCLC

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Byszewska, D., Broniek, A., Jereczek, B., Oblakowski, P., Starzynska, T., Zych, J., & Roszkowski, K. (1997). Chemioterapia versus naprzemienna chemio-radioterapia u chorych z organiczona postacia drobnokomorkowego raka pluca. Pneumonologia i Alergologia Polska, 65(5-6), 318-325.

Chemioterapia versus naprzemienna chemio-radioterapia u chorych z organiczona postacia drobnokomorkowego raka pluca. / Byszewska, D.; Broniek, A.; Jereczek, B.; Oblakowski, P.; Starzynska, T.; Zych, J.; Roszkowski, K.

In: Pneumonologia i Alergologia Polska, Vol. 65, No. 5-6, 1997, p. 318-325.

Research output: Contribution to journalArticle

Byszewska, D, Broniek, A, Jereczek, B, Oblakowski, P, Starzynska, T, Zych, J & Roszkowski, K 1997, 'Chemioterapia versus naprzemienna chemio-radioterapia u chorych z organiczona postacia drobnokomorkowego raka pluca', Pneumonologia i Alergologia Polska, vol. 65, no. 5-6, pp. 318-325.
Byszewska, D. ; Broniek, A. ; Jereczek, B. ; Oblakowski, P. ; Starzynska, T. ; Zych, J. ; Roszkowski, K. / Chemioterapia versus naprzemienna chemio-radioterapia u chorych z organiczona postacia drobnokomorkowego raka pluca. In: Pneumonologia i Alergologia Polska. 1997 ; Vol. 65, No. 5-6. pp. 318-325.
@article{136afad9d6db460bb3b144acc3086877,
title = "Chemioterapia versus naprzemienna chemio-radioterapia u chorych z organiczona postacia drobnokomorkowego raka pluca",
abstract = "62 patients with a limited small cell lung cancer were randomly qualified into two groups. 32 patients of the first group were treated only with the chemotherapy regimen, consisting of three drugs (Carboplatine, Etoposide and Vincristine administered in 6 courses, on a regular, 3-weekly basis). The second group of 30 patients had been treated with the identical chemotherapy schedule, but alternatively combined with a primary site irradiation in a total dose of 40 Gy, applied in parts after the chemotherapy courses 2, 3, and 4. The significantly higher proportion of a complete remission results was observed in the alternate-treatment group: 14/30 (46,7{\%}), compared with the chemotherapy-only group: 10/32 (31{\%}). Alternate chemoradiotherapy resulted both in the increased median remission duration time, and the increased median survival time. Only in the alternate chemotherapy group, in 14/30 patients (46,7{\%}) the pneumotoxicity symptoms appeared, whilst no differences in other organ-specific treatment-induced toxic effects were noted.",
keywords = "chemoradiotherapy, chemotherapy, LD SCLC",
author = "D. Byszewska and A. Broniek and B. Jereczek and P. Oblakowski and T. Starzynska and J. Zych and K. Roszkowski",
year = "1997",
language = "Polish",
volume = "65",
pages = "318--325",
journal = "Gruzlica i choroby pluc; tuberculosis et pneumonologia",
issn = "0867-7077",
publisher = "Instytut Gruzlicy i Chorob Pluc",
number = "5-6",

}

TY - JOUR

T1 - Chemioterapia versus naprzemienna chemio-radioterapia u chorych z organiczona postacia drobnokomorkowego raka pluca

AU - Byszewska, D.

AU - Broniek, A.

AU - Jereczek, B.

AU - Oblakowski, P.

AU - Starzynska, T.

AU - Zych, J.

AU - Roszkowski, K.

PY - 1997

Y1 - 1997

N2 - 62 patients with a limited small cell lung cancer were randomly qualified into two groups. 32 patients of the first group were treated only with the chemotherapy regimen, consisting of three drugs (Carboplatine, Etoposide and Vincristine administered in 6 courses, on a regular, 3-weekly basis). The second group of 30 patients had been treated with the identical chemotherapy schedule, but alternatively combined with a primary site irradiation in a total dose of 40 Gy, applied in parts after the chemotherapy courses 2, 3, and 4. The significantly higher proportion of a complete remission results was observed in the alternate-treatment group: 14/30 (46,7%), compared with the chemotherapy-only group: 10/32 (31%). Alternate chemoradiotherapy resulted both in the increased median remission duration time, and the increased median survival time. Only in the alternate chemotherapy group, in 14/30 patients (46,7%) the pneumotoxicity symptoms appeared, whilst no differences in other organ-specific treatment-induced toxic effects were noted.

AB - 62 patients with a limited small cell lung cancer were randomly qualified into two groups. 32 patients of the first group were treated only with the chemotherapy regimen, consisting of three drugs (Carboplatine, Etoposide and Vincristine administered in 6 courses, on a regular, 3-weekly basis). The second group of 30 patients had been treated with the identical chemotherapy schedule, but alternatively combined with a primary site irradiation in a total dose of 40 Gy, applied in parts after the chemotherapy courses 2, 3, and 4. The significantly higher proportion of a complete remission results was observed in the alternate-treatment group: 14/30 (46,7%), compared with the chemotherapy-only group: 10/32 (31%). Alternate chemoradiotherapy resulted both in the increased median remission duration time, and the increased median survival time. Only in the alternate chemotherapy group, in 14/30 patients (46,7%) the pneumotoxicity symptoms appeared, whilst no differences in other organ-specific treatment-induced toxic effects were noted.

KW - chemoradiotherapy

KW - chemotherapy

KW - LD SCLC

UR - http://www.scopus.com/inward/record.url?scp=0030877278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030877278&partnerID=8YFLogxK

M3 - Articolo

VL - 65

SP - 318

EP - 325

JO - Gruzlica i choroby pluc; tuberculosis et pneumonologia

JF - Gruzlica i choroby pluc; tuberculosis et pneumonologia

SN - 0867-7077

IS - 5-6

ER -